143 related articles for article (PubMed ID: 35569011)
21. [New insights into the pathophysiology of oedema in nephrotic syndrome].
Rondon-Berrios H
Nefrologia; 2011; 31(2):148-54. PubMed ID: 21461007
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
23. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes.
Deschênes G; Doucet A
J Am Soc Nephrol; 2000 Apr; 11(4):604-615. PubMed ID: 10752519
[TBL] [Abstract][Full Text] [Related]
24. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B
Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
[TBL] [Abstract][Full Text] [Related]
25. Proteinuric diseases with sodium retention: Is plasmin the link?
Svenningsen P; Skøtt O; Jensen BL
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):117-24. PubMed ID: 21466573
[TBL] [Abstract][Full Text] [Related]
26. Proteasuria in nephrotic syndrome-quantification and proteomic profiling.
Wörn M; Bohnert BN; Alenazi F; Boldt K; Klose F; Junger K; Ueffing M; Birkenfeld AL; Kalbacher H; Artunc F
J Proteomics; 2021 Jan; 230():103981. PubMed ID: 32927112
[TBL] [Abstract][Full Text] [Related]
27. Nephrotic syndrome is associated with increased plasma K
Ydegaard R; Svenningsen P; Bistrup C; Andersen RF; Stubbe J; Buhl KB; Marcussen N; Hinrichs GR; Iraqi H; Zamani R; Dimke H; Jensen BL
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1549-F1562. PubMed ID: 31566427
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of oedema in nephrotic syndrome: role of epithelial sodium channel.
Kim SW; Frøkiaer J; Nielsen S
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S8-10. PubMed ID: 17995529
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of sodium and water retention in rats with nephrotic syndrome induced by puromycin aminonucleoside.
Xu Z; Wang Y; Feng Y; Yang M; Shi G; Xuan Z; Xu F
BMC Nephrol; 2023 Oct; 24(1):309. PubMed ID: 37880610
[TBL] [Abstract][Full Text] [Related]
31. Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.
Ray EC; Rondon-Berrios H; Boyd CR; Kleyman TR
Adv Chronic Kidney Dis; 2015 May; 22(3):179-84. PubMed ID: 25908466
[TBL] [Abstract][Full Text] [Related]
32. Regulation of sodium transport by ENaC in the kidney.
Hamm LL; Feng Z; Hering-Smith KS
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):98-105. PubMed ID: 19996890
[TBL] [Abstract][Full Text] [Related]
33. Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome.
Artunc F; Nasir O; Amann K; Boini KM; Häring HU; Risler T; Lang F
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1624-34. PubMed ID: 18768591
[TBL] [Abstract][Full Text] [Related]
34. Increased apical targeting of renal ENaC subunits and decreased expression of 11betaHSD2 in HgCl2-induced nephrotic syndrome in rats.
Kim SW; de Seigneux S; Sassen MC; Lee J; Kim J; Knepper MA; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2006 Mar; 290(3):F674-87. PubMed ID: 16189294
[TBL] [Abstract][Full Text] [Related]
35. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
Keeler R
Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
[TBL] [Abstract][Full Text] [Related]
36. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy.
Deschênes G; Wittner M; Stefano AD; Jounier S; Doucet A
J Am Soc Nephrol; 2001 Mar; 12(3):598-601. PubMed ID: 11181809
[TBL] [Abstract][Full Text] [Related]
37. Plasmin in nephrotic urine activates the epithelial sodium channel.
Svenningsen P; Bistrup C; Friis UG; Bertog M; Haerteis S; Krueger B; Stubbe J; Jensen ON; Thiesson HC; Uhrenholt TR; Jespersen B; Jensen BL; Korbmacher C; Skøtt O
J Am Soc Nephrol; 2009 Feb; 20(2):299-310. PubMed ID: 19073825
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on edema in childhood nephrotic syndrome.
Teoh CW; Robinson LA; Noone D
Am J Physiol Renal Physiol; 2015 Oct; 309(7):F575-82. PubMed ID: 26290369
[TBL] [Abstract][Full Text] [Related]
39. A variant of ASIC2 mediates sodium retention in nephrotic syndrome.
Fila M; Sassi A; Brideau G; Cheval L; Morla L; Houillier P; Walter C; Gennaoui M; Collignon L; Keck M; Planelles G; Bakouh N; Peuchmaur M; Deschênes G; Anegon I; Remy S; Vogt B; Crambert G; Doucet A
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34166227
[TBL] [Abstract][Full Text] [Related]
40. New role for plasmin in sodium homeostasis.
Passero CJ; Hughey RP; Kleyman TR
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):13-9. PubMed ID: 19864949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
